Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Amarin CEO to Step Down; Replacement Named

Irish biopharmaceutical firm Amarin Corporation (NASDAQ: AMRN  ) will get a new CEO in the new year.

On Monday, Amarin announced that current company President John F. Thero will also become its Chief Executive Officer on Jan. 1. On that date, he will also join the company's Board of Directors.

Thero will replace current CEO Joseph S. Zakrzewski, who has announced his intention to retire from both the CEO's post and give up his position as Chairman of the Board, to become an ordinary director, also on Jan. 1. Zakrzewski was named Amarin CEO in November 2010.

Thero will not be Chairman of the Board. That post goes to current Lead Independent Director Lars Ekman.

In a press release, Amarin noted that Thero "has been a key executive of Amarin since November 2009 and has contributed substantial executive leadership and operational value to the company. Expanding John's role to CEO was the natural decision as the company embarks on the next stages of its commercial growth." The company is currently awaiting a decision from the U.S. Food and Drug Administration on whether its prescription-strength Vascepa omega 3 fatty acid pill can be used for purposes other than treating patients with high triglyceride levels. This decision may come out as early as Friday. A panel of outside advisers to the FDA voted against recommending the broader use in mid-October. Vascepa is the company's only product.

Amarin shares have lost 80% of their value over the past year. As of this writing, the shares had shed a further 1.7% today.

-- Material from The Associated Press was used in this report.



Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2766531, ~/Articles/ArticleHandler.aspx, 9/29/2016 2:52:51 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,214.37 -124.87 -0.68%
S&P 500 2,158.69 -12.68 -0.58%
NASD 5,291.26 -27.29 -0.51%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 2:37 PM
AMRN $3.14 Down -0.11 -3.24%
Amarin CAPS Rating: ****